Breast Surgery Follow-Up Study with Imaging Technology
Part of Cancer clinical trials.
This study follows patients who had breast surgery using special imaging tools (MOLLI, SPY-PHI, or SPY AGENT GREEN) to see how well these tools help surgeons and how patients recover. Your information helps doctors understand if these tools work safely and effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were at least 18 years old when you had your breast surgery
- You had breast surgery using one of these imaging tools: MOLLI, SPY-PHI, or SPY AGENT GREEN
- Your surgery was on or after January 2022
- At least 1 month has passed since your surgery
- You were not pregnant or breastfeeding at the time of your surgery
- You are not currently enrolled in another experimental drug or device study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects breast cancer imaging tests to build a teaching library. You can join if you are 18 or older and have had a breast imaging test in the US.
This trial compares different imaging schedules after breast-conserving surgery for people with a higher risk of recurrence. It tests whether more frequent or different types of scans can catch any return of cancer earlier.
This study tests a tool called BREASTChoice AIM1-B, which helps people who have had breast surgery make informed choices about their follow-up care. You may be eligible if you had a mastectomy or lumpectomy in the past 8 years for breast cancer or to lower your risk.
This study tests a new imaging tool that helps surgeons see cancer margins in real time during a lumpectomy, aiming to reduce the need for a second surgery. It is for women with early-stage breast cancer who are planning a lumpectomy.
This study uses molecular breast imaging (MBI) to help guide biopsies for women with breast abnormalities. It has two parts: one for women with past MBI findings that turned out to be benign, and another for women who need a biopsy now based on recent imaging.
This trial looks at new tools to detect lymphedema (breast or arm swelling) after breast cancer treatment. If you had breast-conserving surgery, radiation, and have finished active therapy (except certain hormone treatments), researchers want to see if a simple device can spot fluid buildup early.
Hear when a new Breast Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.